• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995-2010 年瑞典-丹麦艾滋病毒队列中的艾滋病毒护理,缩小差距。

HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps.

机构信息

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

出版信息

PLoS One. 2013 Aug 15;8(8):e72257. doi: 10.1371/journal.pone.0072257. eCollection 2013.

DOI:10.1371/journal.pone.0072257
PMID:23967292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3744451/
Abstract

BACKGROUND

Successful treatment reduces morbidity, mortality and transmission of HIV. We evaluated trends in the treatment status of HIV infected individuals enrolled in care in Sweden and Denmark during the years 1995-2010. Our aim was to assess the proportion of HIV-infected individuals who received services along the continuum of care in Denmark in 2010, and to discuss the findings in relation to the organization of the health care system.

METHODS

We analyzed CD4 counts and viral loads (VL) among all HIV patients enrolled in the cohort. For each month of the study period we estimated the proportions of patients who 1) had initiated highly active antiretroviral treatment (HAART) and had VL<500 copies/mL, 2) were not eligible for HAART, 3) had initiated HAART but had VL≥500 copies/mL, 4) were eligible for, but had not initiated HAART and 5) had initiated HAART but no VL monitoring for >13 months or 6) no HAART or monitoring of CD4 for >13 months. Patients fulfilling criteria 1 or 2 were considered successfully managed.

RESULTS

The proportion of successfully managed patients continued to increase throughout the study period and reached 83% in 2010, 92% of Swedish/Danish men who have sex with men and heterosexual patients, but only 74% of immigrants and 78% of injection drug users were successfully managed due to higher rates of inadequate monitoring in the latter two groups. In 2010, 70% of all individuals diagnosed with HIV in Denmark were virally suppressed.

CONCLUSION

In a public health care system with free access to specialized care, successful management of the majority of HIV patients is achievable. Interventions tailored to retain immigrants and injection drug users in care are needed to further reduce the proportion of sub-optimally treated HIV patients.

摘要

背景

成功的治疗可降低 HIV 的发病率、死亡率和传播率。我们评估了 1995-2010 年期间在瑞典和丹麦接受护理的 HIV 感染者的治疗状况趋势。我们的目的是评估 2010 年丹麦沿着护理连续体接受服务的 HIV 感染者的比例,并结合卫生保健系统的组织讨论这些发现。

方法

我们分析了所有入组队列的 HIV 患者的 CD4 计数和病毒载量(VL)。对于研究期间的每个月,我们估计了以下患者的比例:1)已启动高效抗逆转录病毒治疗(HAART)且 VL<500 拷贝/ml,2)不适合 HAART,3)已启动 HAART 但 VL≥500 拷贝/ml,4)适合但尚未启动 HAART,5)已启动 HAART,但 VL 监测>13 个月,6)未启动 HAART 或 CD4 监测>13 个月。符合标准 1 或 2 的患者被认为得到了成功管理。

结果

成功管理患者的比例在整个研究期间持续增加,到 2010 年达到 83%,瑞典/丹麦男男性行为者和异性恋患者的比例为 92%,但由于后两组监测不足的比例较高,移民和注射吸毒者中只有 74%和 78%得到了成功管理。2010 年,丹麦诊断出的所有 HIV 患者中有 70%病毒受到抑制。

结论

在一个拥有免费获得专业护理的公共卫生保健系统中,大多数 HIV 患者的成功管理是可以实现的。需要采取有针对性的干预措施,让移民和注射吸毒者继续留在护理中,以进一步减少治疗效果不理想的 HIV 患者的比例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/3114b452db18/pone.0072257.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/e7dd15ea4509/pone.0072257.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/56b72b898cf6/pone.0072257.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/3114b452db18/pone.0072257.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/e7dd15ea4509/pone.0072257.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/56b72b898cf6/pone.0072257.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6394/3744451/3114b452db18/pone.0072257.g003.jpg

相似文献

1
HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps.1995-2010 年瑞典-丹麦艾滋病毒队列中的艾滋病毒护理,缩小差距。
PLoS One. 2013 Aug 15;8(8):e72257. doi: 10.1371/journal.pone.0072257. eCollection 2013.
2
Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.性别对 HIV-1 感染患者接受高效抗逆转录病毒治疗反应的影响:一项全国性基于人群的队列研究。
BMC Infect Dis. 2012 Nov 12;12:293. doi: 10.1186/1471-2334-12-293.
3
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.2000 年至 2008 年美国艾滋病毒感染者抗逆转录病毒治疗使用、HIV RNA 血浆病毒载量和 CD4 淋巴细胞计数的趋势。
Ann Intern Med. 2012 Sep 4;157(5):325-35. doi: 10.7326/0003-4819-157-5-201209040-00005.
4
Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.高效抗逆转录病毒疗法能否减少艾滋病毒的传播?:在南非一个城镇进行的一项研究。
J Acquir Immune Defic Syndr. 2004 May 1;36(1):613-21. doi: 10.1097/00126334-200405010-00010.
5
Factors associated with 10 years of continuous viral load suppression on HAART.与高效抗逆转录病毒治疗(HAART)后持续10年病毒载量抑制相关的因素。
BMC Infect Dis. 2016 Jul 22;16:351. doi: 10.1186/s12879-016-1677-x.
6
Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.在一个加勒比发展中国家的非临床试验环境中,对高效抗逆转录病毒疗法的免疫和病毒学反应。
HIV Med. 2006 Mar;7(2):99-104. doi: 10.1111/j.1468-1293.2006.00347.x.
7
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.启动高效抗逆转录病毒治疗后头6至18个月的病毒学控制作为HIV感染患者预后的预测指标:一项基于丹麦人群的6年随访研究。
Clin Infect Dis. 2006 Jan 1;42(1):136-44. doi: 10.1086/498515. Epub 2005 Nov 30.
8
Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.注射吸毒对HIV-1感染患者高效抗逆转录病毒治疗反应的影响:一项基于全国人群的队列研究。
Scand J Infect Dis. 2010 Dec;42(11-12):917-23. doi: 10.3109/00365548.2010.511258. Epub 2010 Sep 15.
9
Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies.自高效抗逆转录病毒疗法引入以来,城市诊所中CD4细胞计数和血浆病毒血症的总体趋势。
Clin Microbiol Infect. 2001 Dec;7(12):678-81. doi: 10.1046/j.1469-0691.2001.00340.x.
10
Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.对感染1型人类免疫缺陷病毒的儿童采用高效抗逆转录病毒疗法进行治疗,与对生长的持续影响相关。
Pediatrics. 2002 Feb;109(2):E25. doi: 10.1542/peds.109.2.e25.

引用本文的文献

1
How do migrants living with HIV adhere to the HIV care process in high-income countries? A systematic review.在高收入国家,感染艾滋病毒的移民如何坚持接受艾滋病毒护理流程?一项系统综述。
BMJ Open. 2025 May 8;15(5):e093620. doi: 10.1136/bmjopen-2024-093620.
2
Statistical methods applied for the assessment of the HIV cascade and continuum of care: a systematic scoping review.应用于评估 HIV 级联和护理连续体的统计方法:系统范围界定综述。
BMJ Open. 2023 Nov 23;13(11):e071392. doi: 10.1136/bmjopen-2022-071392.
3
Successful expanded clinic network collaboration and patient tracing for retention in HIV care.

本文引用的文献

1
Response to the AIDS pandemic--a global health model.应对艾滋病大流行——一种全球健康模式。
N Engl J Med. 2013 Jun 6;368(23):2210-8. doi: 10.1056/NEJMra1201533.
2
Disparities in engagement in care and viral suppression among persons with HIV.艾滋病毒感染者参与护理和病毒抑制方面的差异。
J Acquir Immune Defic Syndr. 2013 May 1;63(1):112-9. doi: 10.1097/QAI.0b013e3182894555.
3
Sweden health system review.瑞典医疗体系综述。
成功扩大诊所网络合作并追踪患者以保持其接受 HIV 护理。
AIDS Res Ther. 2022 Dec 5;19(1):61. doi: 10.1186/s12981-022-00476-x.
4
Finnish HIV Quality of Care Register (FINHIV).芬兰艾滋病毒护理质量登记(FINHIV)。
BMJ Open. 2022 Jan 21;12(1):e053287. doi: 10.1136/bmjopen-2021-053287.
5
Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999-2018).一切都很重要——一种使用 HIV 护理连续体的纵向数据来确定艾滋病毒感染者病毒抑制情况的方法——两项大型、德国、多中心真实队列研究 20 多年(1999-2018 年)的结果。
BMC Public Health. 2021 Jan 22;21(1):200. doi: 10.1186/s12889-020-10088-7.
6
Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.提高在欧洲使用指征性疾病引导的 HIV 检测的证据:HIDES II 研究的结果-2012-2015 年。
PLoS One. 2019 Aug 13;14(8):e0220108. doi: 10.1371/journal.pone.0220108. eCollection 2019.
7
Challenges in modelling the proportion of undiagnosed HIV infections in Sweden.在瑞典建模未确诊的 HIV 感染比例方面面临的挑战。
Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800203.
8
Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention.在基于网络的干预措施背景下,识别、联系并治疗注射吸毒且近期感染艾滋病毒的人群。
AIDS Care. 2019 Nov;31(11):1376-1383. doi: 10.1080/09540121.2019.1601671. Epub 2019 Apr 2.
9
Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study.加拿大安大略省确诊 HIV 感染者接受 HIV 护理链服务的趋势:一项回顾性、基于人群的队列研究。
PLoS One. 2019 Jan 4;14(1):e0210096. doi: 10.1371/journal.pone.0210096. eCollection 2019.
10
A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination.一项关于丹麦男男性行为者中 HIV 流行情况的建模研究:旅行、暴露前预防和消除。
Sci Rep. 2018 Oct 30;8(1):16003. doi: 10.1038/s41598-018-33570-0.
Health Syst Transit. 2012;14(5):1-159.
4
Causes of death among Danish HIV patients compared with population controls in the period 1995-2008.1995-2008 年丹麦 HIV 患者与普通人群对照的死亡原因。
Infection. 2012 Dec;40(6):627-34. doi: 10.1007/s15010-012-0293-y. Epub 2012 Jul 12.
5
Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex.尽管丹麦男男性行为者(MSM)安全性行为的参与度增加,但 HIV 诊断的发病率仍保持稳定。
J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):106-11. doi: 10.1097/QAI.0b013e31825af890.
6
Virologic suppression in treatment-experienced patients after virologic rebound or failure of therapy.治疗后病毒学反弹或治疗失败的治疗经验患者的病毒学抑制。
Curr Opin HIV AIDS. 2011 Dec;6 Suppl 1:S12-20. doi: 10.1097/01.COH.0000410240.65647.23.
7
Vital signs: HIV prevention through care and treatment--United States.生命体征:通过护理和治疗预防艾滋病毒——美国。
MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23.
8
Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort.丹麦全国性艾滋病病毒队列中的晚期就诊者、重复检测及错失的机会
Scand J Infect Dis. 2012 Apr;44(4):282-8. doi: 10.3109/00365548.2011.626440. Epub 2011 Nov 8.
9
Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study.非 HIV 和 HIV 风险因素对接受高效抗逆转录病毒治疗的 HIV 感染患者生存的影响:一项基于人群的全国性队列研究。
PLoS One. 2011;6(7):e22698. doi: 10.1371/journal.pone.0022698. Epub 2011 Jul 25.
10
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.